- Home
- DRCT vs BMRA Comparison
DRCT vs BMRA Comparison
Compare DRCT & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- BMRA
- Stock Information
- Founded
- DRCT 2018
- BMRA 1971
- Country
- DRCT United States
- BMRA United States
- Employees
- DRCT N/A
- BMRA N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DRCT Technology
- BMRA Health Care
- Exchange
- DRCT Nasdaq
- BMRA Nasdaq
- Market Cap
- DRCT 10.2M
- BMRA 11.2M
- IPO Year
- DRCT 2022
- BMRA N/A
- Fundamental
- Price
- DRCT $0.64
- BMRA $0.48
- Analyst Decision
- DRCT Strong Buy
- BMRA
- Analyst Count
- DRCT 1
- BMRA 0
- Target Price
- DRCT $23.00
- BMRA N/A
- AVG Volume (30 Days)
- DRCT 1.7M
- BMRA 205.9K
- Earning Date
- DRCT 03-27-2025
- BMRA 04-14-2025
- Dividend Yield
- DRCT N/A
- BMRA N/A
- EPS Growth
- DRCT N/A
- BMRA N/A
- EPS
- DRCT N/A
- BMRA N/A
- Revenue
- DRCT $62,288,000.00
- BMRA $5,678,000.00
- Revenue This Year
- DRCT $53.01
- BMRA N/A
- Revenue Next Year
- DRCT $11.11
- BMRA N/A
- P/E Ratio
- DRCT N/A
- BMRA N/A
- Revenue Growth
- DRCT N/A
- BMRA 5.01
- 52 Week Low
- DRCT $0.44
- BMRA $0.24
- 52 Week High
- DRCT $8.11
- BMRA $1.27
- Technical
- Relative Strength Index (RSI)
- DRCT 47.16
- BMRA 41.24
- Support Level
- DRCT $0.44
- BMRA $0.40
- Resistance Level
- DRCT $0.63
- BMRA $0.61
- Average True Range (ATR)
- DRCT 0.10
- BMRA 0.05
- MACD
- DRCT 0.01
- BMRA -0.01
- Stochastic Oscillator
- DRCT 76.83
- BMRA 38.10
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.